Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Luc Faillie

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Pharmacological Research|July 9, 2016
Pharmacological aspects of the safety of gliflozinsJean-Luc Faillie
Therapie|November 28, 2017
[Case-non case studies: Principles, methods, bias and interpretation]Jean-Luc Faillie
Therapie|February 19, 2019
Case-non-case studies: Principle, methods, bias and interpretationJean-Luc Faillie
Therapie|December 10, 2014
[Immortal time bias in pharmacoepidemiological studies: definition, solutions and examples]Jean-Luc Faillie, Samy Suissa
Therapie|November 25, 2018
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetesFrancesco Salvo, Jean-Luc Faillie
Therapie|October 17, 2021
The discovery of hypoglycaemic sulphonamides - Montpellier, 1942Thierry Lavabre-Bertrand, Jean-Luc Faillie
Therapie|November 20, 2023
Drug-induced hyperglycemia and diabetesMarie-Anne Heurtebize, Jean-Luc Faillie
Therapie|May 20, 2020
Diabetes and COVID-19Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, et al.
Plos Neglected Tropical Diseases|November 6, 2024
Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance databasePamella Modingam, Jean-Luc Faillie, Jérémy T Campillo
Therapie|May 9, 2021
[Diabetes and COVID-19]Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Pharmacological Research|July 9, 2016
Pharmacological aspects of the safety of gliflozinsJean-Luc Faillie
Therapie|November 28, 2017
[Case-non case studies: Principles, methods, bias and interpretation]Jean-Luc Faillie
Therapie|February 19, 2019
Case-non-case studies: Principle, methods, bias and interpretationJean-Luc Faillie
Therapie|December 10, 2014
[Immortal time bias in pharmacoepidemiological studies: definition, solutions and examples]Jean-Luc Faillie, Samy Suissa
Therapie|November 25, 2018
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetesFrancesco Salvo, Jean-Luc Faillie
Therapie|October 17, 2021
The discovery of hypoglycaemic sulphonamides - Montpellier, 1942Thierry Lavabre-Bertrand, Jean-Luc Faillie
Therapie|November 20, 2023
Drug-induced hyperglycemia and diabetesMarie-Anne Heurtebize, Jean-Luc Faillie
Therapie|May 20, 2020
Diabetes and COVID-19Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, et al.
Plos Neglected Tropical Diseases|November 6, 2024
Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance databasePamella Modingam, Jean-Luc Faillie, Jérémy T Campillo
Therapie|May 9, 2021
[Diabetes and COVID-19]Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, et al.
Pageof 8